Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | https://onlinelibrary.wiley.com/doi/10.1111/pde.15708 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1867019649863909376 |
|---|---|
| author | Aditya K. Gupta Shruthi Polla Ravi Tong Wang Sara Faour Mary A. Bamimore Candrice R. Heath Sheila Fallon Friedlander |
| author_facet | Aditya K. Gupta Shruthi Polla Ravi Tong Wang Sara Faour Mary A. Bamimore Candrice R. Heath Sheila Fallon Friedlander Aditya K. Gupta Shruthi Polla Ravi Tong Wang Sara Faour Mary A. Bamimore Candrice R. Heath Sheila Fallon Friedlander |
| collection | Wiley Open Access |
| contents | An update on tinea capitis in children Aditya K. Gupta Shruthi Polla Ravi Tong Wang Sara Faour Mary A. Bamimore Candrice R. Heath Sheila Fallon Friedlander Pediatric Dermatology AbstractTinea capitis presents a significant public health care challenge due to its contagious nature, and potential long‐term consequences if unrecognized and untreated. This review explores the prevalence, risk factors, diagnostic methods, prevention strategies, impact on quality of life, and treatment options for pediatric tinea capitis. Epidemiological analysis spanning from 1990 to 1993 and 2020 to 2023 reveals prevalence patterns of pediatric tinea capitis influenced by geographic, demographic, and environmental factors. Notably, Trichophyton species is most prevalent in North America; however, Microsporum species remain the primary causative agent globally, with regional variations. Risk factors include close contact and environmental conditions, emphasizing the importance of preventive measures. Accurate diagnosis relies on clinical evaluation, microscopic examination, and fungal culture. Various treatment modalities including systemic antifungals show efficacy, with terbinafine demonstrating superior mycological cure rates particularly for Trichophyton species. Recurrent infections and the potential development of resistance can pose challenges. Therefore, confirming the diagnosis, appropriately educating the patient/caregiver, accurate drug and dose utilization, and compliance are important components of clinical cure. Untreated or poorly treated tinea capitis can lead to chronic infection, social stigma, and psychological distress in affected children. Prevention strategies focus on early detection and healthy lifestyle habits. Collaborative efforts between healthcare providers and public health agencies are important in treating pediatric tinea capitis and improving patient outcomes. Education and awareness initiatives play a vital role in prevention and community‐level intervention to minimize spread of infection. Future research should explore diagnostic advances, novel treatments, and resistance mechanisms in order to mitigate the disease burden effectively. 10.1111/pde.15708 http://creativecommons.org/licenses/by-nc/4.0/ |
| doi_str_mv | 10.1111/pde.15708 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_pde_15708 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | An update on tinea capitis in children Aditya K. Gupta Shruthi Polla Ravi Tong Wang Sara Faour Mary A. Bamimore Candrice R. Heath Sheila Fallon Friedlander Pediatric Dermatology An update on tinea capitis in children Aditya K. Gupta Shruthi Polla Ravi Tong Wang Sara Faour Mary A. Bamimore Candrice R. Heath Sheila Fallon Friedlander Pediatric Dermatology AbstractTinea capitis presents a significant public health care challenge due to its contagious nature, and potential long‐term consequences if unrecognized and untreated. This review explores the prevalence, risk factors, diagnostic methods, prevention strategies, impact on quality of life, and treatment options for pediatric tinea capitis. Epidemiological analysis spanning from 1990 to 1993 and 2020 to 2023 reveals prevalence patterns of pediatric tinea capitis influenced by geographic, demographic, and environmental factors. Notably, Trichophyton species is most prevalent in North America; however, Microsporum species remain the primary causative agent globally, with regional variations. Risk factors include close contact and environmental conditions, emphasizing the importance of preventive measures. Accurate diagnosis relies on clinical evaluation, microscopic examination, and fungal culture. Various treatment modalities including systemic antifungals show efficacy, with terbinafine demonstrating superior mycological cure rates particularly for Trichophyton species. Recurrent infections and the potential development of resistance can pose challenges. Therefore, confirming the diagnosis, appropriately educating the patient/caregiver, accurate drug and dose utilization, and compliance are important components of clinical cure. Untreated or poorly treated tinea capitis can lead to chronic infection, social stigma, and psychological distress in affected children. Prevention strategies focus on early detection and healthy lifestyle habits. Collaborative efforts between healthcare providers and public health agencies are important in treating pediatric tinea capitis and improving patient outcomes. Education and awareness initiatives play a vital role in prevention and community‐level intervention to minimize spread of infection. Future research should explore diagnostic advances, novel treatments, and resistance mechanisms in order to mitigate the disease burden effectively. 10.1111/pde.15708 http://creativecommons.org/licenses/by-nc/4.0/ |
| title | An update on tinea capitis in children |
| topic | Pediatric Dermatology |
| url | https://onlinelibrary.wiley.com/doi/10.1111/pde.15708 |